Relationship Between Anemia and Telogen Effluvium in Post-COVID-19 Survivors

Relationship Between Anemia and Telogen Effluvium in Post-COVID-19 Survivors

Authors

  • Canan Emiroglu Dıskapı Yıldırım Beyazıt Training and Research Hospital
  • Murat Dicle Dıskapı Yıldırım Beyazıt Training and Research Hospital
  • Suleyman Gorpelioglu Dıskapı Yıldırım Beyazıt Training and Research Hospital
  • Cenk Aypak Dıskapı Yıldırım Beyazıt Training and Research Hospital

Keywords:

COVID-19,, anemia, iron deficiency anemia, hair shedding, inflammation

Abstract

Introduction: There are insufficient studies in the literature on the relationship between the acute severity of the disease and the occurrence of anemia and telogen effluvium (TE) in the post-coronavirus disease 2019 (COVID-19) period.

Objectives: The purpose of this study is to investigate the relationship between anemia and TE in individuals who have experienced COVID-19 during the post-COVID period.

Method: The study has a retrospective, cross-sectional design and was conducted on patient presented to a tertiary care hospital for COVID-19 follow-up. Patient data, including demographic parameters, data regarding smoking history, comorbidities, symptoms and laboratory panel at presentation, were evaluated.

Results: Out of of 672 patients, 249 had TE complaints. TE was more common in women, those under the average age of this patient group, and those with a body mass index of under 25. Anemia was identified in 80 patients. Among individuals with anemia, TE is observed in 47.3%, whereas among those without anemia, the occurrence of TE is noted at a rate of 35.5%. When the severity of infection in the acute phase was examined in relation to the presence of TE in the post-COVID period, TE was observed in 45.1% of those receiving outpatient treatment, 37.0% of those hospitalized and 30.7% of those in intensive care.

Conclusion: The results obtained in this study group indicate that TE complaints after COVID-19 are more common in those with anemia, but the fact that they were not correlated with the acute diseases’ severity requires consideration of other causes besides the virus effect.

 

References

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 Aug 9;11(1):16144. DOI: 10.1038/s41598-021-95565-8.

Seeẞle J, Waterboer T, Hippchen T, et al. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022 Apr 9;74(7):1191-1198. DOI: 10.1093/cid/ciab611.

Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med. 2023 Apr 19;133(4):16402. DOI: 10.20452/pamw.16402.

Taneri PE, Gómez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020 Aug;35(8):763-773. DOI: 10.1007/s10654-020-00678-5.

Abu-Ismail L, Taha MJJ, Abuawwad MT, et al. COVID-19 and Anemia: What Do We Know So Far? Hemoglobin. 2023 May;47(3):122-129. DOI: 10.1080/03630269.2023.2236546.

Huerga Encabo H, Grey W, Garcia-Albornoz M, et al. Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients. Stem Cell Reports. 2021 Mar 9;16(3):428-436. DOI: 10.1016/j.stemcr.2021.02.001.

Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID-19 infection. Dermatol Ther. 2021 Mar;34(2):e14761. DOI: 10.1111/dth.14761.

Rizzetto G, Diotallevi F, Campanati A, et al. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther. 2021 Jan;34(1):e14547. DOI: 10.1111/dth.14547.

Aksoy H, Yıldırım UM, Ergen P, Gürel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021 Nov;34(6): e15175. DOI: 10.1111/dth.15175.

Starace M, Iorizzo M, Sechi A, et al. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021 Dec; 5:11-18. DOI: 10.1016/j.jdin.2021.07.006.

Kumar A, Sharma E, Marley A, Samaan MA, Brookes MJ. Iron deficiency anaemia: pathophysiology, assessment, practical management. BMJ Open Gastroenterol. 2022;9(1):e000759. DOI: 10.1136/bmjgast-2021-000759.

Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603-2611. DOI: 10.1182/blood-2016-10-569186.

Emiroglu C, Gorpelioglu S, Ozagar SD, Demir P, Aypak C. Prevalence and risk factors of psychological symptoms and quality of life in COVID-19 survivors: A cross-sectional study of three different populations. Int J Nurs Pract. 2023 Sep 28:e13202. DOI: 10.1111/ijn.13202.

Bergamaschi G, Borrelli de Andreis F, Aronico N, et al; Internal Medicine Covid-19 Collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021 May;21(2):239-246. DOI: 10.1007/s10238-020-00679-4.

Tao Z, Xu J, Chen W, et al. Anemia is associated with severe illness in COVID-19: A retrospective cohort study. J Med Virol. 2021 Mar;93(3):1478-1488. DOI: 10.1002/jmv.26444.

Sonnweber T, Grubwieser P, Sahanic S, et al. The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study. Metabolites. 2022 Jun 14;12(6):546. DOI: 10.3390/metabo12060546.

Kakpovbia E, Ogbechie-Godec OA, Shapiro J, Lo Sicco KI. Laboratory Testing in Telogen Effluvium. J Drugs Dermatol. 2021 Jan 1;20(1):110-111. DOI: 10.36849/JDD.5771.

İbiş S, Aksoy Saraç G, Akdağ T. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. Dermatol Pract Concept. 2022 Jul 1;12(3):e2022151. DOI: 10.5826/dpc.1203a151

Yorulmaz A, Hayran Y, Ozdemir AK, et al. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. J Cosmet Dermatol. 2022 Jun;21(6):2610-2617. DOI: 10.1111/jocd.14413.

Arslan H, Gündüz Ö. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023202. DOI: 10.5826/dpc.1303a202.

Koç Yıldırım S, Erbağcı E, Demirel Öğüt N. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium? J Cosmet Dermatol. 2022 May;21(5):1809-1815. DOI: 10.1111/jocd.14883.

Downloads

Published

2025-01-29

How to Cite

1.
Emiroglu C, Dicle M, Gorpelioglu S, Aypak C. Relationship Between Anemia and Telogen Effluvium in Post-COVID-19 Survivors. Dermatol Pract Concept. 2025;15(1):4234. doi:10.5826/dpc.1501a4234

Share